TABLE 4.
Group | Na | Ar | N | Cyp19a1 | N | Esr1 | N | Esr2 |
---|---|---|---|---|---|---|---|---|
V-F | 10 | 1.03 ± 0.07b | 9 | 1.10 ± 0.16 | 10 | 1.06 ± 0.13 | 10 | 1.04 ± 0.10 |
V-M | 10 | 0.90 ± 0.07 | 10 | 1.01 ± 0.20 | 10 | 0.82 ± 0.05 | 10 | 0.79 ± 0.05 |
TP-F | 10 | 0.82 ± 0.04 | 10 | 1.29 ± 0.22 | 10 | 0.86 ± 0.03 | 10 | 0.81 ± 0.06 |
TP-M | 10 | 1.06 ± 0.09 | 10 | 1.09 ± 0.20 | 10 | 0.91 ± 0.03 | 10 | 0.80 ± 0.06 |
N: number of mice in each group;
Relative mRNA levels of each gene were calculated and expressed as relative to the average of vehicle-treated females.